ARTICLE | Clinical News
Bavituximab: Interim Phase III data
October 17, 2016 7:00 AM UTC
Interim data from the double-blind, international Phase III SUNRISE trial in about 582 previously treated patients with stage IIIb/IV non-squamous NSCLC showed that once-weekly IV bavituximab plus doc...